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Abstract Objective of the study is to assess the efficacy
of a brief motivational enhancement intervention in ado-
lescents referred to psychiatric treatment who reported
substance-use. In a sample of adolescents (n = 237) con-
secutively admitted to a psychiatry department, 143 were
identified as users. Subjects were randomly allocated to one
of two groups: an experimental group that received a brief
intervention aimed at increasing their awareness of the
risks of substance-use, or a control group. All subjects
received standard treatment according to the primary
diagnosis. Structured questionnaires assessing knowledge,
problems, perception of risks and intention of use of psy-
choactive substances were administered upon admission
and 1 month later. Fifty-nine subjects entered the experi-
mental group and 44 the control group. No significant
differences between the two groups were identified
in socio-demographic features or substance-use. Non-
parametric analyses showed a significant increase across
time in overall knowledge about drugs and perception of
risk in the experimental group (P \ 0.05). A significant
increase in overall knowledge in the experimental group
compared to controls was found (P \ 0.05). No differences
were observed for other variables such as intention of use
or perception of risk. Brief intervention in adolescents
entering psychiatric treatment led to a significant change in
overall knowledge about psychoactive substances but not
in other variables related to use. Our results point to the
need of more intensive interventions.
Keywords Adolescent  Substance-use 
Brief intervention  Child psychiatry
Introduction
According to data from the Spanish Drugs Observatory
over a 10-year period (1994–2004) a twofold increase in
the prevalence of recent cannabis use (last 30 days) and a
threefold increase in the prevalence of recent cocaine use
among adolescents aged 14–18 has been reported. Fur-
thermore, a decrease in the age of first use has been
reported [26]. A limited knowledge of drug effects and
subsequent low perception of risks related to substance-use
has been noted as a factor (among others) that might
contribute to these changes in substance-use among ado-
lescents [24]. Research on substance-use disorders has
stressed the importance of prevention and early interven-
tion among adolescents to improve the awareness of sub-
stance-use risks. In this regard, a meta-analysis of
preventive school-based programs has shown that those
based on interactive rather than directive techniques are
more effective [29].
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Motivational interviewing (MI) is a style of behavior
change counseling developed originally to help people
change substance-abuse behaviors [18]. The principles of
MI include understanding the client’s view, avoiding
resistances by means of a non-confrontational approach
and increasing clients’ self-efficacy and the perceived
discrepancy between their behavior and their current and
long-term goals. Over the years this model of intervention
has been shown to be effective in enhancing motivation
towards change in several health-related behaviors [8].
Furthermore, some authors have stressed the importance of
capitalizing on a teachable moment or window of oppor-
tunity [3], which provides good reason to conduct inter-
ventions in medical settings such as emergency rooms after
a consultation related to substance-use. To implement such
interventions, short therapeutic consultations delivered
according to the principles of MI have been developed.
These approaches, called brief interventions (BI), usually
last 1–5 sessions and include several stages: assessment,
feedback, information, advice and providing self-help
materials [4]. BI have been shown to be effective in
reducing substance-use, particularly among non-dependent
subjects, attaining a good cost-effectiveness relationship
[20]. Studies have yielded some positive results for brief
interventions aimed at decreasing substance-use among
adolescents in different settings, such as emergency rooms
or outpatient settings (general practitioners, pediatric out-
patient units) and even in high schools [10, 13, 27]. An
important issue when considering brief interventions is the
targeted population. Interventions in vulnerable groups
such as those already showing drug-related health problems
have been tested; Tait et al. [28] demonstrated the effec-
tiveness of a brief intervention with adolescents who were
seen in hospital emergency departments for presentations
related to alcohol use, for instance. However, one of the so-
called high-risk adolescent populations, those who present
a comorbid psychiatric condition, has been less investi-
gated. Prevalence of use, abuse and dependence in ado-
lescent psychiatric population has been reported to be high
[21], and comorbid psychiatric disorders among adoles-
cents with substance disorders are highly prevalent, with
rates reaching 88% [6].
The objective of the present study was to assess the
short-term efficacy of a brief intervention that aimed to
change attitudes and thoughts about substance-use among
adolescent substance users who were undergoing psychi-
atric or psychological treatment because of another disor-
der not primarily related to substance-use. In light of
reports which consider that brief interventions capitalizing
on a teachable moment are more likely to be effective, we
predicted that these adolescents attending a psychiatric unit
for non-drug related disorders would be receptive to such
an intervention and more willing to change.
Methods
Subjects
The present study formed part of an epidemiological and
treatment study of the substance-use behaviors of a cohort
of adolescents entering psychiatric treatment. Adolescents
aged 12–17 years consecutively referred for psychiatric or
psychological assessment and treatment to a Child and
Adolescent Psychiatry and Psychology Department com-
pleted an assessment protocol that included questions
regarding their substance-use. Patients who refused to
participate (n = 48), those who did not complete a sub-
stantial part of the protocol (n = 33), those (n = 10) who
suffered from acute psychopathological disturbances
(psychotic state, severe depression), and patients who
presented mental retardation (n = 15) were excluded.
Another six patients were referred to a residential center for
a more intensive intervention before finishing the evalua-
tion protocol and were consequently not included in this
study. Four of them presented a severe substance-use dis-
order. Finally, 237 individuals and their tutors completed
the baseline evaluation protocol and were included in the
epidemiological study. Those patients who reported sub-
stance-use (according to the study criteria, see below) were
considered eligible for the present study and were invited
to take part in the treatment trial.
Procedure
The epidemiological and the intervention study were
explained to the adolescents and their parents or mentors,
and written informed consent was obtained. Subjects were
then assessed with a test battery in accordance with a
protocol approved by the Ethics Committee of the institu-
tion. Whenever substance-use was identified, subjects who
were willing to participate in the intervention study were
randomly allocated to one of two possible conditions: an
intervention group in which, after completion of the
baseline evaluation, both the adolescent and his/her parents
each received one separate individual session; and a control
group [treatment as usual (TAU)] in which no further
intervention was delivered. Control group will be referred
from now on and throughout this paper as TAU group.
Probands in both groups entered the protocol at the
beginning of the treatment in the department, not having
received previous treatment in our service. After inclusion
and baseline evaluation was completed, subjects in both the
intervention and the TAU group received standard care
according to the established diagnoses and the intervention
schedule of the Child and Adolescent Psychiatry and
Psychology Department. TAU comprised diagnostic eval-
uation according to the presenting problem, and an initial
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therapeutic approach, either pharmacological and/or cog-
nitive-behavioral therapy. The observation period for all
probands undertook 1 month, thus including no more than
2–4 sessions. Therefore, most of TAU consisted of the
completion of the initiated diagnostic evaluation and gen-
eral therapeutic recommendations on behalf of the evolving
psychiatric diagnoses. Follow-up visits took place at
1 month and included a reevaluation of part of the study
variables. Follow-up evaluators were blind to the condition
of intervention or TAU group.
Study variables
Socio-demographic characteristics and psychiatric
diagnosis
Children were evaluated via semi-structured interviews
based on those used in the Collaborative Studies on
Genetics of Alcoholism (COGA) Project [11], which were
translated and adapted into Spanish. These interviews
provided measures of socio-demographic variables: age,
gender, socioeconomic status, psychiatric status and school
achievement, among other variables. An initial diagnosis
was determined according to DSM-IV [1]. Primary diag-
noses were grouped into five possible categories: mood
disorders, anxiety disorders, adjustment disorders, exter-
nalizing disorders (including ADHD and conduct disor-
ders) and eating disorders. Comorbid diagnoses were
explored and ascertained.
Substance-use pattern
Quantity and frequency measures of substance-use were
obtained from the semi-structured interview and patients’
clinical records. In order to improve the assessment,
patients were not required to disclose their drug use to
their parents. Accordingly, the pattern of use of tobacco,
alcohol, cannabis and other substances (basically,
cocaine, amphetamines and designer drugs) was coded
into five categories as follows: 1, no use; 2, occasional
use: from time to time, at parties, during holidays or
social events; 3, regular use: almost daily use for tobacco,
almost weekly use for alcohol and cannabis, almost
monthly use for stimulants or other drugs, with no clear
evidence of drug-related problems; 4, substance-use
problems (SUP): quantity–frequency and/or situational
pattern of use with a high probability of developing
health or psycho-social problems, now or in the future,
but still sub-diagnostic; and 5, diagnosis of abuse or
dependence according to DSM-IV-TR criteria. Subjects
were also interviewed using a Spanish version of the
Teen Addiction Severity Index (T-ASI) [7], a semi-
structured interview adapted to adolescents from the
Adult Addiction Severity Index (ASI) [12]. The version
used in this study includes 142 items that assess problems
usually related with drug use in seven domains. Severity
of problems in each domain is scored on a five-point
scale (0–4) according to both patient subjective criteria
and interviewer criteria. For analytic purposes we divided
the sample into two groups according to scores on the
Teen ASI drug subscale, each group including subjects
with either minor to moderate (0–2) versus severe prob-
lems (3–4) with drugs.
Variables related to use
Structured questionnaires were employed to assess several
areas of interest regarding subjects’ thoughts about psy-
choactive substances. Questionnaires were obtained from
the Spanish version of the Evaluation Instrument Bank
(EIB) and from the European Monitoring Centre for Drugs
and Drug Addiction (EMCDDA) [14], and were used to
assess the following areas:
Knowledge about psychoactive substances A 31-item
questionnaire that assesses whether the subject has accurate
knowledge about the effects of psychoactive substances
(e.g., ‘‘alcohol is a stimulant substance’’).
Risk perception A 13-item questionnaire to be rated on a
4-point response scale and which evaluates the subjects’
view of the potential harm related to the use of different
substances.
Problems derived from use An 8-item questionnaire to be
scored on a 4-point scale (never, 1 or 2 times, 3 or 4 times,
more than 5 times) and which enquires about the past
presentation of drug-related problems and psychosocial
consequences (e.g., being ill, fights, legal problems, etc.).
Intention to use In this questionnaire the probability of
using several psychoactive substances is scored on a 5-
point scale (1, ‘‘highly probable use’’ to 5, ‘‘very improb-
able use’’). Higher scores in this questionnaire indicate a
lower probability of use.
Intervention
Intervention group
After completion of baseline evaluation, patients allocated
to the intervention group received a brief therapeutic
intervention designed according to the standards of moti-
vational interviewing and adapted from previous work on
this topic [15]. The intervention consisted of:
Eur Child Adolesc Psychiatry (2010) 19:503–511 505
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• An individual session with the adolescent. This inter-
view lasted approximately 60 min. Materials related to
the interview were developed according to previous
reports on the subject [15–17]. The mentioned inter-
vention had been previously manualized by the original
authors, contacted by the authors, and it was translated
and adapted to the Spanish language. The intervention
considered altogether 12 points to be discussed during
the session: (1) contact, (2) feedback from the evalu-
ation, (3) analysis of an episode of substance-use, (4)
pros and cons of substance-use, (5) personal goals, (6)
problems and risks of substance-use, (7) explore
preoccupations, (8) making decisions, (9) questions
and answers, (10) decisional balance, (11) planning
changes, (12) self-monitoring. Through this planned
structure therapists focused initially in building a good
rapport, and the interviewer involved the patient in an
initial discussion about the results of the evaluation.
This led to a review of the drugs used by the subject
and an elicitation of positives and negatives of drug
use. According to the particular areas of interest
reflected by the subject, the relationship between drug
use and current and long-term goals was explored.
Possible discrepancies and hypothetical problems in the
future related to substance-use were examined, and
information and counseling was offered. A decisional
balance was developed and, if accepted by the subject,
advice and exploration of suitable tools to plan
changes in substance-use were offered. At each point,
the basic components of the motivational interview
approach (empathy, non-confrontation, acceptance
and support of self-efficacy and autonomy) were
contemplated and several techniques and skills were
planned [e.g., (1) contact: open questions; (4) pros and
cons: Open questions, reflective listening, and pointing
dissonance].
• An individual session with parents or mentors. This
interview consisted in the presentation of educational
materials and a brief counseling intervention on
parenting skills and adolescent substance-use, its con-
sequences and the relevance of monitoring and
intervention.
Training on the intervention was provided by a doctoral
level supervisor experienced in motivational interviewing
training. Training consisted in over 20 h session time that
included role-playing and direct supervision of the imple-
mentation of motivational interviewing techniques and
skills and the adherence to the manualized intervention. All
interventions were conducted by the same two psycholo-
gists with significant clinical experience in treating sub-
stance-use disorders. During the trial, at least 15% of the
performed interventions were supervised by external
observers and feedback was provided to the interviewers by
the supervisor.
Treatment as usual (TAU)
Individuals assigned to this group and their parents or
tutors received standard care and no further intervention
other than completion of the assessment protocol. As
described previously, standard care consisted of psychiatric
and psychological examination and interviewing with both
the parents and the patients. Diagnostic procedures and
therapeutic recommendations were delivered on behalf of
the evolving diagnoses, and were naturalistically set by the
professionals in the department according of the practice
guidelines of the department. Visits were offered in a
1–2 week basis.
Statistical analyses
Baseline variables in the two groups were compared for
equivalence. Categorical variables were analyzed with v2
and numerical variables by means of the Student’s t test.
To assess short-term changes in the several variables
related to drug use, the scores on the psychometric scales at
baseline and at 1-month follow-up were analyzed as the
main outcome variable. Study variables were first checked
for distributional assumptions by means of the Kolmogorov
–Smirnov test. Due to skewness in the distribution of
variables, the Wilcoxon signed-rank test was used to
compare mean scores on the scales between baseline and
the endpoint (1 month) evaluation in the two groups. Fur-
thermore, a univariate analysis of variance with baseline
scores as the covariate (ANCOVA) was performed to
compare differences in scores on the psychometric scales
between the two groups. Data were analyzed using an
intention to treat approach.
Results
One hundred and forty-three adolescents (60.3%) of the
237 who completed the baseline evaluation were identified
as substance users, with five of them qualifying for sub-
stance abuse or dependence (other than nicotine) according
to the study criteria. Seventy-eight individuals were allo-
cated to the intervention group; nine subjects refused to
participate in the brief intervention trial and ten subjects
were lost to follow-up. Sixty-five individuals were assigned
to the TAU group; 21 out of them were lost to follow-up
(see Fig. 1). Follow-up interviews were conducted at
1 month. Finally, 59 in the intervention group and 44 in the
TAU were included in the analysis. The mean age of
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participants was 15.2 years (SD 1.2) with a range of
12–17 years; 75.7% (n = 78) of participants were female.
Socio-demographic characteristics of the participants in
the two groups, including age, gender distribution, socio-
economic status, main and comorbid psychiatric diagnosis
are shown in Table 1. Substance-use indicators, including
age of onset and average frequency of use among partici-
pants in both groups are shown in Table 2. No significant
differences were found between the two randomized
groups in terms of socio-demographic features. A trend
towards a difference in baseline scores in the drug subscale
of the T-ASI between the two groups was found (t = -1.9;
P = 0.06) though it did not reach statistical significance.
According to scores on the T-ASI drug subscale, subjects
were divided into two groups, each one including subjects
with either minor to moderate (0–2) versus severe prob-
lems (3–4) with drugs. Percentage of subjects reporting
severe problems were not significantly different between
the two groups.
The Wilcoxon signed-rank test revealed a significant
change over time (1 month after baseline assessment) in
scores on the overall knowledge of psychoactive substances
questionnaire in both the TAU group (z = -2.08;
P = 0.03) and the intervention group (z = -4.08;
P = 0.0001). Furthermore, there was a significant change
in perception of risks after the intervention among partic-
ipants in the experimental group (z = -1.97; P = 0.04)
but not among subjects in the TAU group (z = -0.85;
P = 0.39). Scores on the Problems with drugs scale and
the Intention to use scale did not change significantly over
time among participants in either of the two groups (see
Table 3).
To further assess differences between the two groups as
regards short-term changes (1 month) in scores on the
psychometric scales used, we performed a group analysis
of variance with baseline scores on the scales as a covariate
Assessed for eligibility  
(n= 237) 
Not meeting inclusion criteria 
(n = 94) 
59 completed trial 
9 refused 
10 drop outs 
Allocated to intervention 
(n = 78) 
21 drop outs 
Allocated to TAU 
(n = 65) 
44 completed trial 
Allocation
Analysis 
Follow-Up 
143 eligible and 
randomized
Fig. 1 Patient flowchart across study
Table 1 Socio-demographic characteristics, school achievement and
psychiatric diagnosis
Intervention
(n = 59)
TAU
(n = 44)
Statistic
test
P
value
Age
Mean (SD) 15.4 (1.2) 15.1 (1.2) t = -
1.41
0.16a
12–13 years [N (%)] 3 (5.1) 3 (6.7) v2 = 4.4 0.11b
14–15 years [N (%)] 25 (42.4) 27 (61.5)
16–17 years [N (%)] 31 (52.5) 14 (31.8)
Gender
Male [N (%)] 18 (30.5) 7 (15.9) v2 = 2.92 0.1b
Female [N (%)] 41 (69.5) 37 (84.1)
Socioeconomic status N (%)
Low 1 (1.7) 1 (2.2) v2 = 0.74 0.68b
Medium 54 (91.6) 40 (90.9)
High 4 (6.7) 3 (6.8)
Main diagnosis N (%)
Mood disorders 8 (13.5) 4 (9.1) v2 = 4.4 0.35b
Eating disorder 22 (37.4) 25 (56.9)
Externalizing
disorder
18 (30.5) 11 (25)
Anxiety disorders 5 (8.5) 2 (4.5)
Adjustment
disorders
6 (10.1) 2 (4.5)
Comorbid diagnosis
No comorbid
diagnosis
38 26 v2 = 5.1 0.4
Mood disorder 5 10
Conduct disorder 6 3
Anxiety disorder 4 3
Adjustment
disorders
2 1
substance-use
disorder
4 1
School achievement [N (%)]
Low 19 (32.2) 15 (34.1) v2 = 0.51 0.97b
Medium 29 (49.1) 21 (47.7)
High 11 (18.7) 8 (18.2)
SUD Substance-use related disorders, TAU treatment as usual, SD
standard deviation
a Student’s t
b Chi-square
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(ANCOVA), the mean difference between baseline and
endpoint scores as the dependent variable, and allocation to
intervention or TAU group as the grouping factor. This
analysis revealed a significant difference between the two
groups in the mean difference between baseline and end-
point scores on the questionnaire measuring overall
knowledge about psychoactive substances (F = 6.25;
P = 0.01). None of the differences between the two groups
in their scores on the Problems with Drugs, Intention to
Use or Perception of Risks scales reached statistical sig-
nificance (see Table 3). Since a trend towards a difference
between both groups in the severity of baseline use was
found, to assess the possible influence of baseline sub-
stance-use in the group differences we performed another
Table 2 Substance-use
parameters at baseline
SDU Standard drink units, TAU
treatment as usual, SD standard
deviation
a Student’s t
b Chi-square
Intervention
(n = 59)
TAU
(n = 44)
Statistic
test
P value
Alcohol [mean (SD)]
Monthly average SDU 3.4 (4.6) 3.8 (6) t = -0.28 0.78a
Episodes of use [5 SDU 5.5 (15.5) 7.2 (19.9) t = 0.38 0.7a
Age onset 13.4 (1.7) 13.3 (1.4) t = -0.41 0.67a
Tobacco [mean (SD)]
Average cigarettes/week 50.9 (65.7) 51.5 (63.6) t = -0.85 0.4a
Age onset 12.4 (2.0) 12.4 (1.8) t = -0.14 0.88a
Cannabis [mean (SD)]
Average ‘‘joints’’/week 5.6 (10.8) 5.8 (16.4) t = -1.16 0.24a
Age onset 13.7 (1.3) 13.8 (1.5) t = 0.56 0.57a
Other drugs [mean (SD)]
Episodes of use 3.9 (14.8) 3.6 (16.9) t = -0.34 0.72a
Age onset 14.9 (1.1) 14.8 (15) t = -0.26 0.79a
Baseline scores in T-ASI
drug subscale [mean (SD)]
2.3 (0.95) 2.09 (1.09) t = -1.9 0.06a
Substance-use severity
(according to T-ASI)
Minor problems [N (%)] 38 (64) 34 (77) v2 = 2.57 0.12b
Severe problems [N (%)] 21 (36) 10 (22)
Prevalence of regular substance
users (other than tobacco) [N (%)]
42 (71) 25 (56) v2 = 2.28 0.14b
Table 3 Changes in drug-scale scores at 1-month follow-up
Intervention (n = 59) TT as usual (n = 44) Group
differencesb
Group
differencesc
Baseline [mean
(SD)]
1 month [mean
(SD)]
z P Baseline [mean
(SD)]
1 month [mean
(SD)]
z P F P F P
Knowledge 16.9 (4.8) 19.6 (4.8) 4.08 0.0001a 16.1 (4.2) 17.2 (4.5) 2.08 0.03a 6.25 0.01b 9.63 0.003c
Problems 11.7 (4.2) 11.8 (4.2) 1.05 0.29 10.7 (4.1) 10.9 (3.4) 0.61 0.54 0.72 0.39 0.27 0.6
Intention to
use
37.7 (7) 37.5 (5.1) 0.62 0.53 36.8 (5.1) 37.9 (6.5) 0.83 0.4 0.97 0.32 0.44 0.5
Perception of
risk
39.7 (8.2) 41.8 (6.1) 1.97 0.04a 40 (7.9) 40.1 (7.7) 0.85 0.39 2.24 0.137 3.24 0.67
TT as usual Treatment-as-usual group, SD standard deviation
a Wilcoxon signed-rank test
b Analysis of variance with baseline score as covariate (ANCOVA), mean difference between baseline and endpoint scores as the dependent
variable, and allocation to intervention or TAU group as the grouping factor
c Analysis of variance with baseline score and baseline severity of use as covariates (ANCOVA), mean difference between baseline and endpoint
scores as the dependent variable, and allocation to intervention or TAU group as the grouping factor
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ANCOVA, with the same parameters but adding the
severity of use according to baseline T-ASI scores as
covariate. A significant difference between the two groups
in the scores on the Knowledge scale persisted (F = 9.6;
P = 0.003). No group differences in the rest of the scales
were found (Problems, Intention of Use, Perception of
Risk).
Discussion
In a group of patients attending a psychiatry and psychol-
ogy department, the BI resulted in a significant increase in
knowledge about the effects of psychoactive substances
and an increased awareness of their implicit risks. The
TAU group also experienced an increase in their knowl-
edge, but the difference between the two groups reached
statistical significance and favored the experimental group.
When comparing the results in both groups considering
baseline scores as a covariate, the difference in risk per-
ception lost its significance. No other significant differ-
ences between the two conditions were found for the other
outcome variables, and intention to use did not differ over
time between the two groups.
Perception of risks has been proposed as a factor linked
to the likelihood of substance use among adolescents [24];
the more favorable the attitude of young people towards
substance-use, the lower the perception of risk and the
more mistaken their beliefs [19]. Thus, increased knowl-
edge about the real effects of psychoactive substances and
a better perception of the risks involved can be regarded as
a significant beneficial effect of the intervention. However,
other authors have failed to confirm that risk perception is a
core indicator of substance-use [30], and argue that per-
ceived pleasure or benefits constitute a more significant
predictor of the intention and frequency of use.
Though an increase in the knowledge is regarded a
positive outcome, the small change in the psychometric
scale scores, coupled with the lack of concurrent changes
in the intention of use, all points towards an undermined
effect of the brief intervention in this sample.
There may be several explanations for these results. Our
original prediction was that adolescents attending a psy-
chiatric unit for non-drug related disorders would be
receptive to such an intervention. In contrast, it could be
that our studied population is less likely to benefit from
such an intervention. The sample consisted of adolescents
who already present with a primary psychiatric diagnosis
that have led to the need for a mental examination, and
such individuals represent a subgroup at risk of developing
substance-use problems. However, these subjects might
also present a greater lack of insight due to their psycho-
pathology. Lack of insight is both one of the targets of
motivational interviewing, as well as one of the factors that
contribute to resistance. It has been shown that among
adult psychiatric patients with comorbid substance-use
disorders, motivational interviewing, although feasible,
only yields modest and short-term effects, and more
extensive interventions might therefore be recommended
[2].
On the other hand, it has been previously noted, at least
for alcohol disorders, that BI are less effective among those
subjects with substance dependence than for those with less
severe substance-use problems [5]. This suggests that BI
techniques may be an appropriate form of intervention with
adolescents who present less entrenched substance-use
behaviors, whereas such an intervention is too short for
those with more severe problems. We tested this hypothesis
in our trial and found that baseline level of use, coded in
two categories according to scores on the teen ASI drug
subscale [minor to moderate (0–2) vs. severe problems
(3–4) with drugs], did not significantly influence the dif-
ference between both groups (intervention vs. TAU).
Nevertheless, it should be borne in mind that defining
the severity of substance-use among adolescents using a
categorical approach is questionable and might not fit well
with our data. Debates on the conceptualization of disor-
ders arising from the use of cannabis (and other substances)
among adolescents question the current dichotomy
between cannabis abuse and dependence [23]. Some
authors propose a dimensional approach towards cannabis-
use disorders in adolescents that could possibly yield more
appropriate predictive power in terms of prognosis and
therapeutic needs [9].
Age also appears to be an important predictor of treat-
ment outcome in BI, as shown by data from a meta-analytic
review of the efficacy of these interventions [31]. Shake-
shaft et al. found that a brief motivational intervention was
more efficacious among clients who were older at baseline,
indicating that older participants in their study were more
active in treatment and less likely to withdraw. Adolescent
patients might thus be less receptive to such an intervention
[25].
Another possible explanation would be that the inter-
vention was insufficient, either in its quality or quantity.
Our protocol design considered the need to ensure the
quality of the intervention provided, and a significant effort
in manualizing and training was done. The interviewers
adhered well to the principles of motivational interviewing,
however, we are aware that the absence of an objective
measurement of the supervision performed of the delivered
intervention during the trial represents a shortcoming.
Thus, a possible qualitative lack in the delivered inter-
vention, though less likely in our view, must be considered
as a potential explanation to our results. The ‘‘amount’’ of
therapy offered was established on the basis of previous
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reports of BI in adolescents [15], and once again the design
adhered well to the model of BI. A possible shortcoming
could be related to the fact that although BI have proven to
be efficient in previous controlled trials, most of these
studies have focused on specific behaviors such as cigarette
smoking or alcohol use. In contrast, studies reporting on BI
oriented toward broader aspects (e.g., substance-use as a
whole, considering several different substances) have not
reported the same efficacy [16].
It might also be asked whether the chosen outcome
measures constitute a good measure of the benefits gener-
ated by our intervention. The selected psychometric scales
are included in a comprehensive bank of standardized
instruments that provide valuable information on sub-
jective features related to adolescents’ substance-use.
However, we are aware that these scales have not been
designed for prospective assessment in the context of an
intervention trial. Another limitation derives from the fact
that no biological test (e.g., urinary or saliva drug test) was
performed at baseline to ensure the accuracy of the self-
report. Nevertheless, substance-use assessment by means
of self-report questionnaires and direct interviews with
adolescents has been proven to be efficient in previous
studies [22].
Further limitations could rely on the fact that our sample
consisted of 75.7% of female participants. This resulted
from a nonstratified recruiting procedure (subjects were
included consecutively) with our department having sub-
stantially increased number of female adolescents, since it
runs an important Eating Disorder program. Literature on
the topic usually states that drug use is a much more
common issue among boys. However, we consider that this
issue is not a major limitation in terms of exploring the
efficacy of the intervention since both the experimental and
the TAU group in this sample presented a similar gender
distribution. Yet, it could limit the generalization of our
results to the general population.
In our study, both groups received a standard care
treatment program throughout the observation period, and
it is unlikely that this standard care, although not specifi-
cally intended to assess and treat substance-use related
problems, did not have an effect on the probands. At the
time of developing the present study, no specific treatment
program for substance-use among adolescents attending
our department was offered. Thus, diagnosis and treatment
of comorbid substance-use was delivered by the profes-
sionals in the treatment setting. Professionals were aware
of the inclusion of patients in our trial, and were told not to
change their approach to substance-use. Hence, we must
consider that throughout the observation period, the pro-
bands in both the TAU and the intervention groups expe-
rienced an intervention for their primary psychiatric
condition and a subsequent, non-controlled intervention for
their substance-use, which might have influenced the study
outcomes. Nevertheless, participants in both groups only
showed changes over time in their knowledge about psy-
choactive substances, without changes in intention to use
and the other variables. Thus, we can conclude that the
standard treatment program as a whole only had a subtle
effect on the substance-use of the patients. On the other
hand, changes in overall knowledge differed between the
two groups, being specifically more intense among the
patients who received the brief intervention. And patients
in the intervention group showed a change across time in
perception of risk (although this was not significant when
compared to the TAU group).
Conclusions
An important conclusion that can be drawn from these
results is that implementation of specific targeted
programs among this population is an urgent need,
since standard care programs seem to not succeed in
significantly changing attitudes towards substance-use in
adolescents, particularly among those already showing
substance-use problems. Brief interventions have an effect
on the probands, although a minor one, and probably need
to be more intense or qualitatively different in this spe-
cific population.
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